A Future Leader of Epigenetic Cancer Diagnosis and Drug Research

        Lisen is extending the application of its QCIGISH technology for the in vitro diagnosis of different cancer types including breast, colon, esophageal, gastric, liver cancer, among others, using multiple screening methods.